WASHINGTON (Reuters) – Pharmaceutical company Akorn Inc has won U.S. antitrust approval to buy specialty prescription drug company VersaPharm Inc on condition it sell its rights to a generic…

from Reuters: Deals http://ift.tt/UOtsKU
via IFTTT

Publicités